Prelude Therapeutics
Paul A. Friedman is on the Board of Directors at Prelude Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Prelude Therapeutics
3 followers
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways.